Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 8-K Event Results of operations
  2. DEF 14A Proxy Proxy Statement
  3. UPLOAD Other SEC-generated Letter
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 4 Open-market sale Director sold 3,000 shares at $83.28 ($249,840)
  6. 4 Open-market sale Senior Vice President sold 10,000 shares at an average $81.29 ($812,942)
  7. 4 Open-market sale Chief Financial Officer sold 13,038 shares at an average $81.02 ($1,056,310)
  8. 4 Open-market sale Chief Commercial Officer sold 15,625 shares at $75.00 ($1,171,875)
  9. 4 Open-market sale General Counsel sold 25,000 shares at an average $72.41 ($1,810,346)
  10. 4 Open-market sale Chief Financial Officer sold 30,625 shares at an average $72.44 ($2,218,477)
  11. 4 Open-market sale Senior Vice President sold 38,750 shares at an average $72.51 ($2,809,578)
  12. 4 Grant or award General Counsel acquired 60,000 shares (grant or award)
  13. 4 Grant or award Director acquired 9,000 shares (grant or award)
  14. 4 Grant or award Director acquired 9,000 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 60,000 shares (grant or award)
  16. 4 Grant or award Director acquired 9,000 shares (grant or award)
  17. 4 Open-market sale Director sold 4,000 shares at $76.09 ($304,360)
  18. 4 Open-market sale Director sold 4,000 shares at $76.08 ($304,320)
  19. 4 Grant or award Senior Vice President acquired 50,000 shares (grant or award)
  20. 4 Open-market sale Director sold 3,750 shares at $76.08 ($285,300)

Page 21 of 69 · 1,363 filings